Your browser does not support JavaScript or it may be disabled!
 India As It Happens
Rediff Labs will showcase innovative products that rediff is working on behind the scenes.
News   |   Images
Get Realtime News
on your webpage

About 833 results for "nbs"

Nigerian Economy Added 349,343 Jobs in Third Quarter, Says NBS

By James Emejo in Abuja The Nigerian economy added a total of 349,343 jobs in the third quarter of the year compared to 259,353 jobs in the previous quarter, according to the National Bureau of Statistics (NBS). According to the latest Job ... This Day Online, 1 hour ago
349,343 new jobs created in Q3 of 2014, says NBS The Guardian Nigeria, 3 days ago

203 images for nbs, 4 days ago
Northbrook Star, 14 hours ago
Deerfield Review, 14 hours ago
Niles Herald, 1 day ago
Niles Herald, 1 day ago
Northbrook Star, 1 day ago
East Midlands Business News, 1 week ago
Glenview Announcements, 3 days ago
Glenview Announcements, 3 days ago
Glenview Announcements, 3 days ago

NeoStem: Changing The Goalposts Midgame And A Potentially Biased Analyst

Summary NBS recently ran-up in front of expected Phase 2 data. NBS failed its primary endpoint, but changed the endpoint mid-trial. Maxim analyst Jason Kolbert who has a buy on the stock was previously employed by NBS and may own shares. On ...
 Seeking Alpha1 day ago NeoStem (NBS) Offers Additional Data on PreSERVE AMI Phase 2  Wall Street Business Network1 day ago NeoStem Provides Further Information Regarding the Design of the Phase 2 PreSERVE AMI Clinical Trial  CNN Money1 day ago NeoStem, Inc. Provides Further Information Regarding The Design Of The Phase 2 PreSERVE AMI Clinical Trial 11/21/2014  ClinicSpace1 day ago

Neostem Down 12.1%, Shares Slide into the Red (NBS)

Neostem (AMEX:NBS) is one of today's worst performing low-priced stocks, down 12.1% to $3.91 on 3.6x average daily volume. Neostem has traded 1.5 million shares thus far today, vs. average volume of 415,000 shares per day. The stock has ...
 Individual.com1 day ago Hot Stock: Neostem, Shares Drop 8.8% (NBS)  TradingCharts.com1 day ago
Bidness Etc

Midday Losers: November 18

Biggest Losers NeoStem Inc ( NBS ),-28.17%,after the firm released phase 2 results of its NBS10 stem cell therapy yesterday. Omega Protein Corporation ( OME ), -18.48%, on the company's disappointing third-quarter results, released yesterday. ...
 Bidness Etc4 days ago NeoStem (NBS) Stock Plummets Today on Disappointing Cardiac Stem-Cell Therapy Data  TheStreet.com4 days ago Why NeoStem (NBS) Stock Might Fall Further  Bidness Etc4 days ago Disappointing trial results for Neostem  Nation's Restaurant News4 days ago

Neostem Crosses Below its 10-day MA (NBS)

Neostem (AMEX:NBS) crossed under its 10-day moving average of $5.40 on a volume of 2.2 million shares. This may provide swing traders with an opportunity for a short position, as such a crossover often suggests lower prices in the near term.In the ...
 Individual.com4 days ago Strength Seen in Neostem (NBS): Stock Moves 9.9% Higher  Yahoo! Finance4 days ago

NeoStem up again on anticipation of NBS10 Phase 2 data

Thinly-traded micro cap NeoStem (NBS +11.3%) jumps again on a 5x surge in volume. Shares are up 50% from the low of $4.63 on November 6. The company presents results from a Phase 2 trial of NBS10 for treatment of patients with post ST segment ...
 Seeking Alpha5 days ago Buyers Accumulate Shares of Neostem, Up 16.1%  Individual.com5 days ago Stock Investors Bid Up Shares of Neostem, Up 12.9%  Comtex SmarTrend1 week ago

China completes first major oil reserve project

The National Bureau of Statistics (NBS) on Thursday announced that the first phase of the oil reserves project was complete and operational. The reserve project has a total oil storage capacity of 16.4 million cubic meters, with actual oil reserves ...
 Individual.com2 days ago First major oil reserve project completed in China  Want China Times1 day ago 『 China completes first major oil reserve project 』  ECF2 days ago Oil reserve project done, operating  Shanghai Daily2 days ago

NeoStem's Stem Cell Therapy Fails Mid-Stage Heart Attack Study

By: | 11/18/14 - 10:16 AM EST Stocks in this article: NBS Inject a cocktail of undifferentiated stem cellsinto a patient who has suffered a heart attack, and days or even weekslater, the stem cells transform into cardiac cells and ...
 TheStreet.com4 days ago NeoStem, Inc.'s Stem Cell Therapy Fails Mid-Stage Heart Attack Study  BioSpace4 days ago

ACT Buys AGN, NBS Needs A Close Watch, No Pain For TRVN, TKMR Does A Deal

Shares of Actavis plc (ACT: Quote) touched an all-time high on Monday after the company agreed to acquire Allergan Inc. (AGN: Quote) in a deal valued at $66 billion. Brent Saunders, CEO and President of Actavis said, "The combination is expected to ...
 RTTNews.com4 days ago
Business Standard

FinMin writes to fertiliser ministry for expediting process of bring urea under NBS

Few days after the fertiliser ministry announcing no price hike for urea, the finance ministry has written to the fertiliser department to expedite the process for including urea under Nutrient Based Subsidy (NBS) programme. According to ...
 Business Standard India1 week ago Expedite process to bring urea under NBS, FinMin asks Fertiliser Ministry  Business Standard1 week ago FinMin asks Fertiliser Ministry to expedite process to bring urea under NBS  Business Standard India1 week ago
Prev | Next
Personalize your Realtimeclose [x]
Add content to your personalized tab - My News
Add upto 6 topics of your interest:
for eg.2g Scam , World
Personalize the tabs display. ( You can add or remove the tabs )
AlertsGet updates on latest news & your favourite topics right in your inbox.Set an Alert|Manage your Alerts


Realtime News

on your Webpage

Add Widget >Get your members hooked!
Get updated on latest news & your favorite topics right in your inbox!
More     Less